194 related articles for article (PubMed ID: 24107765)
21. Antipsychotic drug use and the risk of venous thromboembolism in elderly patients.
Kleijer BC; Heerdink ER; Egberts TC; Jansen PA; van Marum RJ
J Clin Psychopharmacol; 2010 Oct; 30(5):526-30. PubMed ID: 20814323
[TBL] [Abstract][Full Text] [Related]
22. Antipsychotic drugs and risk of pulmonary embolism.
Allenet B; Schmidlin S; Genty C; Bosson JL
Pharmacoepidemiol Drug Saf; 2012 Jan; 21(1):42-8. PubMed ID: 22052683
[TBL] [Abstract][Full Text] [Related]
23. Use of oral contraceptives containing gestodene and risk of venous thromboembolism: outlook 10 years after the third-generation "pill scare".
Heinemann LA; Dinger JC; Assmann A; Minh TD
Contraception; 2010 May; 81(5):401-7. PubMed ID: 20399946
[TBL] [Abstract][Full Text] [Related]
24. Antipsychotic use and Risk of Venous Thromboembolism: A Meta-Analysis.
Di X; Chen M; Shen S; Cui X
Psychiatry Res; 2021 Feb; 296():113691. PubMed ID: 33421839
[TBL] [Abstract][Full Text] [Related]
25. Antipsychotic drugs and the risk of recurrent venous thromboembolism: A prospective cohort study.
Mollard LM; Le Mao R; Tromeur C; Le Moigne E; Gouillou M; Pan-Petesch B; Delluc A; Couturaud F; Lacut K
Eur J Intern Med; 2018 Jun; 52():22-27. PubMed ID: 29548526
[TBL] [Abstract][Full Text] [Related]
26. Antipsychotic Drugs and Risk of Developing Venous Thromboembolism and Pulmonary Embolism: A Systematic Review and Meta-Analysis.
Arasteh O; Nomani H; Baharara H; Sadjadi SA; Mohammadpour AH; Ghavami V; Sathyapalan T; Sahebkar A
Curr Vasc Pharmacol; 2020; 18(6):632-643. PubMed ID: 32066363
[TBL] [Abstract][Full Text] [Related]
27. Risk factors and clinical impact of postoperative symptomatic venous thromboembolism.
Gangireddy C; Rectenwald JR; Upchurch GR; Wakefield TW; Khuri S; Henderson WG; Henke PK
J Vasc Surg; 2007 Feb; 45(2):335-341; discussion 341-2. PubMed ID: 17264013
[TBL] [Abstract][Full Text] [Related]
28. Antipsychotic drugs and venous thromboembolism.
Tromeur C; Couturaud F
Thromb Res; 2012 Oct; 130 Suppl 1():S29-31. PubMed ID: 23026655
[TBL] [Abstract][Full Text] [Related]
29. Association of influenza vaccination with reduced risk of venous thromboembolism.
Zhu T; Carcaillon L; Martinez I; Cambou JP; Kyndt X; Guillot K; Vergnes MC; Scarabin PY; Emmerich J
Thromb Haemost; 2009 Dec; 102(6):1259-64. PubMed ID: 19967159
[TBL] [Abstract][Full Text] [Related]
30. Three-month mortality rate and clinical predictors in patients with venous thromboembolism and cancer. Findings from the RIETE registry.
Gussoni G; Frasson S; La Regina M; Di Micco P; Monreal M;
Thromb Res; 2013 Jan; 131(1):24-30. PubMed ID: 23141849
[TBL] [Abstract][Full Text] [Related]
31. Impact of sex and traditional cardiovascular risk factors on the risk of recurrent venous thromboembolism: results from the German MAISTHRO Registry.
Linnemann B; Zgouras D; Schindewolf M; Schwonberg J; Jarosch-Preusche M; Lindhoff-Last E
Blood Coagul Fibrinolysis; 2008 Mar; 19(2):159-65. PubMed ID: 18277138
[TBL] [Abstract][Full Text] [Related]
32. Rates of venous thromboembolism occurrence in medical patients among the insured population.
Spyropoulos AC; Hussein M; Lin J; Battleman D
Thromb Haemost; 2009 Nov; 102(5):951-7. PubMed ID: 19888534
[TBL] [Abstract][Full Text] [Related]
33. Psychotropic use and risk of stroke among patients with bipolar disorders: 10-year nationwide population based study.
Wu CS; Wu KY; Lo YR; Huang YW; Tsai YT; Li Y; Tsai HJ
J Affect Disord; 2018 Jan; 226():77-84. PubMed ID: 28964996
[TBL] [Abstract][Full Text] [Related]
34. Non-steroidal anti-inflammatory drugs and venous thromboembolism in women.
Bergendal A; Adami J; Bahmanyar S; Hedenmalm K; Lärfars G; Persson I; Sundström A; Kieler H
Pharmacoepidemiol Drug Saf; 2013 Jun; 22(6):658-66. PubMed ID: 23508885
[TBL] [Abstract][Full Text] [Related]
35. Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study.
Holst AG; Jensen G; Prescott E
Circulation; 2010 May; 121(17):1896-903. PubMed ID: 20404252
[TBL] [Abstract][Full Text] [Related]
36. Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case-control study.
Zornberg GL; Jick H
Lancet; 2000 Oct; 356(9237):1219-23. PubMed ID: 11072939
[TBL] [Abstract][Full Text] [Related]
37. Risk of cerebrovascular adverse events in older adults using antipsychotic agents: a propensity-matched retrospective cohort study.
Mehta S; Johnson ML; Chen H; Aparasu RR
J Clin Psychiatry; 2010 Jun; 71(6):689-98. PubMed ID: 20573328
[TBL] [Abstract][Full Text] [Related]
38. Sleep disorders increase the risk of venous thromboembolism in individuals without sleep apnea: a nationwide population-based cohort study in Taiwan.
Chung WS; Chen YF; Lin CL; Chang SN; Hsu WH; Kao CH
Sleep Med; 2015 Jan; 16(1):168-72. PubMed ID: 25547034
[TBL] [Abstract][Full Text] [Related]
39. Global Risk Profile Verification in Patients with Venous Thromboembolism (GRIP VTE) in 5 Gulf countries.
Al Sayegh F; Almahmeed W; Al Humood S; Marashi M; Bahr A; Al Mahdi H; Bakir S; Al Farhan M
Clin Appl Thromb Hemost; 2009; 15(3):289-96. PubMed ID: 18400764
[TBL] [Abstract][Full Text] [Related]
40. Risk of venous thromboembolism in patients with splenic injury and splenectomy. A nationwide cohort study.
Lin JN; Chen HJ; Lin MC; Lai CH; Lin HH; Yang CH; Kao CH
Thromb Haemost; 2016 Jan; 115(1):176-83. PubMed ID: 26333870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
